Concepedia
Statistics
Publications
12
Citations
565
H-Index
11
Active since
1990
Affiliations
University of Colorado Denver(Current)
University of Colorado Health
University of Colorado Cancer Center
Veterans Health Administration
University of Toledo Medical Center
Pamela L. Rice is an author at University of Colorado Denver specializing in medicine, oncology, and pharmacology.
Publications per year
1990–2010
Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice
Yoshitsugu Horio, Aaron Chen, Pamela L. Rice et al. · Molecular Carcinogenesis · 1996 · 103 citations
Medicine, Genetics, Molecular Genetics +16
Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
Pamela L. Rice, Jennifer Kelloff, Holly Sullivan et al. · PubMed · 2003 · 101 citations
Medicine, Oncology, Pharmacology +14
Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization
Elizabeth F. Redente, Lori D. Dwyer‐Nield, Daniel T. Merrick et al. · American Journal Of Pathology · 2010 · 93 citations · Full text
Medicine, Cancer Biology, Immunology +16
Growth inhibition in G1 and altered expression of cyclin D1 and p27kip-1after forced connexin expression in lung and liver carcinoma cells
Lucas D. Koffler, Stacie Roshong, I Park et al. · Journal of Cellular Biochemistry · 2000 · 87 citations
Life Sciences, Cell Biology, Oncology +16
Inhibition of Extracellular-signal Regulated Kinases 1/2 Is Required for Apoptosis of Human Colon Cancer Cells <b> <i>In vitro</i> </b> by Sulindac Metabolites
Pamela L. Rice, K. Beard, Linda J Driggers et al. · Cancer Research · 2004 · 39 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 12